- March 20, 2026
Loading
A Sarasota biopharmaceutical company raised $2.5 million through a registered direct offering this week. Silo Pharma (Nasdaq: SILO) closed its previously announced offering Oct. 1 for the purchase and sale of 2,857,143 shares of common stock at a price of $0.875 per share, according to a statement.